Beaufort Ilse, Akkerman Elisabeth, van Munster Sanne, Weusten Bas
Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht University, the Netherlands.
Endosc Int Open. 2023 Mar 8;11(3):E221-E229. doi: 10.1055/a-1967-1589. eCollection 2023 Mar.
Barrett's esophagus (BE) surveillance endoscopies are advised for early diagnosis of esophageal adenocarcinoma (EAC). Current guidelines recommend obtaining four-quadrant random biopsies every 2 centimeters of BE length alongside with targeted biopsies if visible lesions are present. Low adherence rates for this random biopsy protocol are widely reported. The aim of this systematic review and meta-analysis was to assess the effect of adherence versus non-adherence to the four-quadrant biopsy protocol on detection of dysplasia in BE patients. We searched for studies that reported effects of adherence and non-adherence to the four-quadrant biopsy protocol on dysplasia detection rates in BE patients. Adherence was defined as taking a minimum of 4 quadrant random biopsies per 2 cm of BE segment. Studies with low risk of bias and without applicability concerns were included in a good quality synthesis. Pooled relative risks (RRs) with 95% confidence interval (CI) of dysplasia detection rates were calculated. A total of 1,570 studies were screened and 8 studies were included. Four studies were included in the good quality synthesis. In the pooled good quality analysis, four-quadrant biopsy protocol adherence significantly increased detection of dysplasia compared to non-adherence (RR 1.90, 95 % CI = 1.36-2.64; I2 = 45 %). Pooled RRs for LGD and HGD/EAC were 2.00 (95 % CI = 1.49-2.69; I2 = 0 %) and 2.03 (95 % CI = 0.98-4.24; I2 = 28 %), respectively. This systematic review and meta-analysis demonstrates that four-quadrant biopsy protocol adherence is associated with increased detection of dysplasia in BE patients. Efforts should be made to increase biopsy protocol adherence rates.
建议对巴雷特食管(BE)进行监测性内镜检查,以早期诊断食管腺癌(EAC)。当前指南建议,在BE长度每2厘米的范围内进行四象限随机活检,若存在可见病变则同时进行靶向活检。广泛报道称,这种随机活检方案的依从率较低。本系统评价和荟萃分析的目的是评估遵循与不遵循四象限活检方案对BE患者发育异常检测的影响。
我们检索了报告遵循和不遵循四象限活检方案对BE患者发育异常检出率影响的研究。依从性定义为每2厘米BE段至少进行4次四象限随机活检。纳入低偏倚风险且无适用性问题的研究进行高质量综合分析。计算发育异常检出率的合并相对风险(RRs)及95%置信区间(CI)。
共筛选了1570项研究,纳入8项研究。4项研究纳入高质量综合分析。在合并的高质量分析中,与不遵循相比,遵循四象限活检方案显著提高了发育异常的检出率(RR 1.90,95% CI = 1.36 - 2.64;I² = 45%)。低级别发育异常(LGD)和高级别发育异常/食管腺癌(HGD/EAC)的合并RRs分别为2.00(95% CI = 1.49 - 2.69;I² = 0%)和2.03(95% CI = 0.98 - 4.24;I² = 28%)。
本系统评价和荟萃分析表明,遵循四象限活检方案与提高BE患者发育异常的检出率相关。应努力提高活检方案的依从率。